RSC Advances,
Journal Year:
2024,
Volume and Issue:
14(47), P. 35005 - 35020
Published: Jan. 1, 2024
In
this
study,
a
novel
drug
delivery
system
based
on
zinc
oxide
nanoparticles
(ZnO
NPs)
was
developed
for
the
enhanced
of
cisplatin
(CPT)
to
improve
cancer
treatment.
International Journal of Molecular Sciences,
Journal Year:
2023,
Volume and Issue:
24(21), P. 15764 - 15764
Published: Oct. 30, 2023
Nano-range
bioactive
colloidal
carrier
systems
are
envisaged
to
overcome
the
challenges
associated
with
treatments
of
numerous
diseases.
Lipid
nanoparticles
(LNPs),
one
extensively
investigated
drug
delivery
systems,
not
only
improve
pharmacokinetic
parameters,
transportation,
and
chemical
stability
encapsulated
compounds
but
also
provide
efficient
targeting
reduce
risk
toxicity.
Over
last
decades,
nature-derived
polyphenols,
vitamins,
antioxidants,
dietary
supplements,
herbs
have
received
more
attention
due
their
remarkable
biological
pharmacological
health
medical
benefits.
However,
poor
aqueous
solubility,
compromised
stability,
insufficient
absorption,
accelerated
elimination
impede
research
in
nutraceutical
sector.
Owing
possibilities
offered
by
various
LNPs,
ability
accommodate
both
hydrophilic
hydrophobic
molecules
availability
preparation
methods
suitable
for
sensitive
molecules,
loading
natural
fragile
into
LNPs
offers
a
promising
solution.
The
primary
objective
this
work
is
explore
synergy
between
nature
nanotechnology,
encompassing
wide
range
aimed
at
encapsulating
therapeutic
within
LNPs.
ACS Applied Materials & Interfaces,
Journal Year:
2024,
Volume and Issue:
16(21), P. 27055 - 27064
Published: May 17, 2024
A
major
contributing
cause
to
breast
cancer
related
death
is
metastasis.
Moreover,
metastasis
often
shows
little
symptoms
until
a
large
area
of
the
organs
occupied
by
metastatic
cells.
Breast
multimodal
imaging
attractive
since
it
integrates
advantages
from
several
modalities,
enabling
more
accurate
detection.
Glycoprotein
CD44
overexpressed
on
most
cells
and
primary
cell
surface
receptor
for
hyaluronan
(HA).
To
facilitate
diagnosis,
we
report
an
indocyanine
green
(ICG)
HA
conjugated
iron
oxide
nanoparticle
(NP-ICG-HA),
which
enabled
active
targeting
HA-CD44
interaction
detected
with
magnetic
particle
(MPI)
near-infrared
fluorescence
(NIR-FI).
When
evaluated
in
transgenic
mouse
model,
NP-ICG-HA
detection
multiple
tumors
MPI
NIR-FI,
providing
comprehensive
images
diagnosis
cancer.
Furthermore,
NP-ICG-HAs
were
lung
model.
Upon
administration,
showed
clear
signals
lungs,
indicating
tumor
sites.
This
first
time
that
HA-based
NPs
have
are
platform
noninvasive
Biomedical Materials,
Journal Year:
2024,
Volume and Issue:
19(2), P. 025026 - 025026
Published: Jan. 12, 2024
Abstract
Hepatocellular
carcinoma
remains
a
challenging
contributor
to
the
global
cancer
and
related
mortality,
claims
approximately
800,000
deaths
each
year.
Dysregulation
or
loss
of
function
mutations
involving
tumor
suppressor
gene,
phosphatase
tensin
homolog
deleted
on
chromosome
ten
(PTEN),
has
been
well-characterized
in
various
cancers
elicit
anomalous
cell
proliferation
oncogenic
transformation.
However,
delivery
bioavailability
genes/drugs
interest
carcinomas
serious
bottleneck
behind
success
any
anti-cancer
formulation.
In
this
study,
we
have
engineered
nanoliposomes
containing
PTEN
plasmids,
plumbagin,
antioxidant
cerium
oxide
nanoparticles
(Lipo-PTEN-Plum)
restore
expression
inhibit
AKT/PI3K
pathway.
The
Lipo-PTEN-Plum
was
quasi-spherical
shape
with
∼110
nm
diameter
∼64%
plumbagin
loading
efficiency.
successfully
internalized
HepG2
cells,
PI3K/AKT
pathway
induce
death
cells
grown
monolayer
form
spheroids.
Mechanistically,
formulation
showed
G2/M
cycle
arrest,
DNA
damage
apoptosis
hepatic
cells.
Other
cellular
events
such
as
Caspase-7
overexpression
PI3K
(phosphoinositide
3-kinase),
AKT
(a
serine/threonine
protein
kinase),
PARP
[Poly
(ADP-ribose)
polymerases],
mTOR
(Mammalian
target
rapamycin)
inhibition
led
mRNA
profile
PTEN,
PI3K,
AKT3,
Caspase-7,
proteins,
primarily
controlling
apoptosis,
suggest
that
exogenous
supply
could
regulate
proteins
thus
progression.
MedComm,
Journal Year:
2024,
Volume and Issue:
5(8)
Published: Aug. 1, 2024
Abstract
Currently,
cancer
is
still
a
leading
cause
of
human
death
globally.
Tumor
deterioration
comprises
multiple
events
including
metastasis,
therapeutic
resistance
and
immune
evasion,
all
which
are
tightly
related
to
the
phenotypic
plasticity
especially
epithelial–mesenchymal
(EMP).
cells
with
EMP
manifest
in
three
states
as
transition
(EMT),
partial
EMT,
mesenchymal–epithelial
transition,
orchestrate
switch
heterogeneity
tumor
via
transcriptional
regulation
series
signaling
pathways,
transforming
growth
factor‐β,
Wnt/β‐catenin,
Notch.
However,
due
complicated
nature
EMP,
diverse
process
not
fully
understood.
In
this
review,
we
systematically
conclude
biological
background,
regulating
mechanisms
well
role
therapy
response.
We
also
summarize
range
small
molecule
inhibitors,
immune‐related
approaches,
combination
therapies
that
have
been
developed
target
for
outstanding
EMP‐driven
deterioration.
Additionally,
explore
potential
technique
EMP‐based
mechanistic
investigation
research,
may
burst
vigorous
prospects.
Overall,
elucidate
multifaceted
aspects
progression
suggest
promising
direction
treatment
based
on
targeting
EMP.